AMRIF
PrivateCompany Overview
AMRIF is a biotechnology company that develops RESCAP, an alkaline phosphatase-based oral enzyme supplement intended for the treatment of chronic inflammatory and age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AMRIF Comparables
Compare AMRIF with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alloksys Life Sciences B.V. | 80% | |
| Theriva Biologics | 71% | |
| AM-Pharma | 71% |
AMRIF Funding Rounds
Historical fundraising activity
AMRIF Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AMRIF's valuation, stock price, and market status.
Is AMRIF a public or private company?
AMRIF is a private company.
What is the current stock price of AMRIF?
AMRIF is a private company with no public stock price. No recent secondary market data is available.
How much is AMRIF worth (valuation)?
Valuation information for AMRIF is not publicly available.
Can I buy AMRIF stock?
AMRIF shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AMRIF's last funding round?
Funding round information for AMRIF is not publicly available.
Who are the main investors in AMRIF?
Investor information for AMRIF is not publicly disclosed.
Will AMRIF IPO soon?
No public IPO plans have been announced for AMRIF.
How can I track AMRIF secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AMRIF's secondary market activity and sign up for updates.